Ilico Genetics
ilico genetics, a spin off of pontificia universidad católica de chile, is developing the first methylated dna based molecular test specifically designed for the early detection of gastric cancer, even years before esophagogastroduodenoscopy (egd, gold standard). with only a blood sample, and even without symptoms, it detects a tumor in the stomach or lesions that could evolve to gastric cancer. the results are dynamic and show the cumulative presence of tumors over time.
Last updated on
About Ilico Genetics
Founded
2020Employees
1-10Category
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
BethlehemState
PennsylvaniaCountry
United StatesIlico Genetics
Find your buyer within Ilico Genetics